Application of high-dose intravenous iron in the treatment of anemia in pregnant and postpartum women

TENG Xin-yuan; WANG Li-quan

doi:10.19538/j.fk2025100108

PDF(958 KB)

Chinese Journal of Practical Gynecology and Obstetrics ›› 2025, Vol. 41 ›› Issue (10) : 986-989. DOI: 10.19538/j.fk2025100108

Application of high-dose intravenous iron in the treatment of anemia in pregnant and postpartum women

Author information +

History +

Abstract

Anemia during pregnancy and the postpartum period is a global public health issue，significantly associated with adverse obstetric outcomes，and iron deficiency （ID） is its primary cause. Currently，novel high-dose intravenous iron formulations，which allow single-dose infusion of ≥1000 mg within 15-30 minutes，have been approved for clinical use in China. However，obstetricians and gynecologists lack sufficient understanding of their efficacy and safety in pregnant and postpartum women. This article discusses the application of high-dose intravenous iron in pregnant and postpartum women.

Key words

high-dose intravenous iron / pregnant and postpartum women / anemia / clinical application

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations

TENG Xin-yuan , WANG Li-quan. Application of high-dose intravenous iron in the treatment of anemia in pregnant and postpartum women[J]. Chinese Journal of Practical Gynecology and Obstetrics. 2025, 41(10): 986-989 https://doi.org/10.19538/j.fk2025100108

References

List( Publishing order | Descend order by publishing year | Descend order by cited within ) Chart analysis

[1]	王永生, 李小芹. 儿童生长迟缓营养干预[J]. 中国实用儿科杂志, 2024, 39(4):273-277. DOI:10.19538/j.ek2024040607. Cited in this article [1]

[2]	Van Doren L, Steinheiser M, Boykin K, et al. Expert consensus guidelines:Intravenous iron uses,formulations,administration,and management of reactions[J]. Am J Hematol, 2024, 99(7):1338-1348. DOI: 10.1002/ajh.27220. Cited in this article [5]

[3]	方灵漪, 王亚娟, 李洁, 等. 异麦芽糖酐铁应用于产后缺铁性贫血的前瞻性、随机、单中心临床试验的效果评估[J]. 实用妇产科杂志, 2025, 41(1): 54-59. DOI:1003-6946(2025)01-0054-06. Cited in this article [3]

[4]	孙文韬, 庄铃香, 马爱霞, 等. 羧基麦芽糖铁治疗中国缺铁性贫血成人患者的成本-效果分析[J]. 中国药房,2023, 34(22): 2750-2755. DOI: 1003-6946(2025)01-0054-06. Cited in this article [2]

[5]	中国药理学会药源性疾病学专业委员会, 广东省药学会. 静脉铁剂的临床应用和药学监护专家共识(2024)[J]. 药物不良反应杂志, 2025, 27(3):129-141. DOI:10.6039/j.issn.1001-0408.2023.22.11. Cited in this article [7]

[6]	中华医学会血液学分会红细胞疾病(贫血)学组. 静脉铁剂应用中国专家共识(2019年版)[J]. 中华血液学杂志, 2019, 40(5):358-362. DOI: 10.3760/cma.j.issn.0253-2727.2019.05.002. Cited in this article [1]

[7]	Hansen R, Sommer VM, Pinborg A, et al. Intravenous ferric derisomaltose versus oral iron for persistent iron deficient pregnant women:a randomised controlled trial[J]. Arch Gynecol Obstet, 2023, 308(4):1165-1173. DOI: 10.1007/s00404-022-06768-x. Cited in this article [1]

[8]	Sugimura M, Ohtani Y, Tamai S, et al. Ferric derisomaltose for the treatment of iron deficiency anemia with postpartum hemorrhage:Results of a single-arm,open-label,phase 3 study in Japan[J]. J Obstet Gynaecol Res, 2023, 49(3):946-955. DOI:10.1016/S0140-6736(23)00278-7. Cited in this article [1]

[9]	Holm C, Thomsen LL, Norgaard A, et al. Single-dose intravenous iron infusion or oral iron for treatment of fatigue after postpartum haemorrhage:a randomized controlled trial[J]. Vox Sang, 2017, 112(3):219-228. DOI:10.1111/vox.12477. Cited in this article [1]

[10]

Bombač Tavčar

, Hrobat

, Gornik

, et al. Maternal fatigue after postpartum anemia treatment with intravenous ferric carboxymaltose vs. intravenous ferric derisomaltose vs. oral ferrous sulphate: a randomized controlled trial[J]. J Clin Med, 2024, 13(3):758. DOI:10.3390/jcm13030758.

Cited in this article [1]

[11]	Jose A, Mahey R, Sharma JB, et al. Comparison of ferric Carboxymaltose and iron sucrose complex for treatment of iron-deficiency anemia in pregnancy- randomised controlled trial[J]. BMC Pregnancy Childbirth, 2019, 19(1):54. DOI:10.1186/s12884-019-2200-3. Cited in this article [1]

[12]

Srimathi

, Revathy

, Bagepally

, et al. Clinical effectiveness of ferric carboxymaltose (iv) versus iron sucrose (iv) in treatment of iron-deficiency anaemia in pregnancy:A systematic review and meta-analysis[J]. Indian J Med Res, 2024, 159(1):62-70. DOI:10.4103/ijmr.ijmr.

Cited in this article [1]

[13]

Breymann

, Milman

, Mezzacasa

, et al. Ferric carboxymaltose vs. oral iron in the treatment of pregnant women with iron-deficiency anemia: an international,open-label,randomized controlled trial (FER-ASAP)[J]. J Perinat Med, 2017, 45(4):443-453. DOI:10.1515/jpm-2016-0050.

Cited in this article [1]

[14]

Vanobberghen

, Lweno

, Kuemmerle

, et al. Efficacy and safety of intravenous ferric carboxymaltose compared with oral iron for the treatment of iron-deficiency anaemia in women after childbirth in Tanzania: a parallel-group,open-label,randomised controlled phase 3 trial[J]. Lancet Glob Health, 2021, 9(2):e189-e198. DOI:10.1016/S2214-109X(20)30448-4.

Cited in this article [2]

[15]	Fraser A, Cairnes V, Mikkelsen E, et al. Understanding and managing infusion reactions and hypophosphataemia with intravenous iron-a nurses' consensus paper[J]. Nurs Open, 2025, 12(4):e70191. DOI:10.1002/nop2.70191. Cited in this article [2]

[16]	Achebe M, DeLoughery TG. Clinical data for intravenous iron-debunking the hype around hypersensitivity[J]. Transfusion, 2020, 60(6):1154-1159. DOI: 10.1111/trf.15837. Cited in this article [4]

[17]

Kennedy

, Achebe

, Biggar

, et al. A systematic literature review and meta-analysis of the incidence of serious or severe hypersensitivity reactions after administration of ferric derisomaltose or ferric carboxymaltose[J]. Int J Clin Pharm, 2023, 45(3):604-612. DOI:10.1007/s11096-023-01548-2.

Cited in this article [1]

[18]	Huang LL, Lee D, Troster SM, et al. A controlled study of the effects of ferric carboxymaltose on bone and haematinic biomarkers in chronic kidney disease and pregnancy[J]. Nephrol Dial Transplant, 2018, 33(9):1628-1635. DOI:10.1093/ndt/gfx310. Cited in this article [1]

[19]	Auerbach M, DeLoughery TG, Tirnauer JS. Iron deficiency in adults: a review[J]. JAMA, 2025, 333(20):1813-1823. DOI:10.1001/jama.2025.0452. Cited in this article [1]

[20]	Wolf M, Rubin J, Achebe M, et al. Effects of iron isomaltoside vs ferric carboxymaltose on hypophosphatemia in iron-deficiency anemia:two randomized clinical trials[J]. JAMA, 2020, 323(5):432-443. DOI: 10.1001/jama.2019.22450. Cited in this article [1]

[21]	赵岩, 刘彩霞, 魏军, 等. 双胎妊娠期缺铁性贫血诊治及保健指南(2023年版)[J]. 中国实用妇科与产科杂志, 2023, 39(4):419-430.DOI:10.19538/j.fk2023040110. Cited in this article [1]

[22]	李莉艳, 王志坚. 妊娠期地中海贫血的管理与遗传咨询[J]. 中国实用妇科与产科杂志, 2022, 38(12):1159-1163.DOI:10.19538/j.fk2022120103. Cited in this article [1]

[23]	赵艳, 吴捷. 儿童胆汁淤积性肝病的营养管理[J]. 中国实用儿科杂志, 2024, 39(4):259-263. DOI:10.19538/j.ek2024040604. Cited in this article [1]